Literature DB >> 33413697

Cancer-associated adipocytes as immunomodulators in cancer.

Qi Wu1, Bei Li2, Juanjuan Li1, Si Sun3, Jingping Yuan4, Shengrong Sun5.   

Abstract

Cancer-associated adipocytes (CAAs), as a main component of the tumor-adipose microenvironment (TAME), have various functions, including remodeling the extracellular matrix and interacting with tumor cells or infiltrated leukocytes through a variety of mutual signals. Here, we summarize the primary interplay among CAAs, the immune response and cancer with a focus on the mechanistic aspects of these relationships. Finally, unifying our understanding of CAAs with the immune cell function may be an effective method to enhance the efficacy of immunotherapeutic and conventional treatments.

Entities:  

Keywords:  Cancer-associated adipocytes; Immune cells; Metabolism; Tumor

Year:  2021        PMID: 33413697      PMCID: PMC7792018          DOI: 10.1186/s40364-020-00257-6

Source DB:  PubMed          Journal:  Biomark Res        ISSN: 2050-7771


  210 in total

1.  Inhibitory effect of tumor cell-derived lactic acid on human T cells.

Authors:  Karin Fischer; Petra Hoffmann; Simon Voelkl; Norbert Meidenbauer; Julia Ammer; Matthias Edinger; Eva Gottfried; Sabine Schwarz; Gregor Rothe; Sabine Hoves; Kathrin Renner; Birgit Timischl; Andreas Mackensen; Leoni Kunz-Schughart; Reinhard Andreesen; Stefan W Krause; Marina Kreutz
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

Review 2.  Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target.

Authors:  Dorothy K Sojka; Yu-Hui Huang; Deborah J Fowell
Journal:  Immunology       Date:  2008-03-14       Impact factor: 7.397

3.  Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells.

Authors:  Chi Ma; Miaojun Han; Bernd Heinrich; Qiong Fu; Qianfei Zhang; Milan Sandhu; David Agdashian; Masaki Terabe; Jay A Berzofsky; Valerie Fako; Thomas Ritz; Thomas Longerich; Casey M Theriot; John A McCulloch; Soumen Roy; Wuxing Yuan; Vishal Thovarai; Shurjo K Sen; Mathuros Ruchirawat; Firouzeh Korangy; Xin Wei Wang; Giorgio Trinchieri; Tim F Greten
Journal:  Science       Date:  2018-05-25       Impact factor: 47.728

4.  Metabolic requirements for neutrophil extracellular traps formation.

Authors:  Oscar Rodríguez-Espinosa; Oscar Rojas-Espinosa; María Maximina Bertha Moreno-Altamirano; Edgar Oliver López-Villegas; Francisco Javier Sánchez-García
Journal:  Immunology       Date:  2015-06       Impact factor: 7.397

Review 5.  M1/M2 macrophage polarization in human obese adipose tissue.

Authors:  Jaroslava Chylikova; Jana Dvorackova; Zdenek Tauber; Vojtech Kamarad
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2018-05-16       Impact factor: 1.245

6.  Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.

Authors:  Stefani Spranger; Daisy Dai; Brendan Horton; Thomas F Gajewski
Journal:  Cancer Cell       Date:  2017-05-08       Impact factor: 31.743

Review 7.  Dendritic Cells and Cancer Immunity.

Authors:  Alycia Gardner; Brian Ruffell
Journal:  Trends Immunol       Date:  2016-10-25       Impact factor: 16.687

8.  Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia.

Authors:  Serkan Kir; James P White; Sandra Kleiner; Lawrence Kazak; Paul Cohen; Vickie E Baracos; Bruce M Spiegelman
Journal:  Nature       Date:  2014-07-13       Impact factor: 49.962

9.  Dendritic cells tolerized with adenosine A₂AR agonist attenuate acute kidney injury.

Authors:  Li Li; Liping Huang; Hong Ye; Steven P Song; Amandeep Bajwa; Sang Ju Lee; Emily K Moser; Katarzyna Jaworska; Gilbert R Kinsey; Yuan J Day; Joel Linden; Peter I Lobo; Diane L Rosin; Mark D Okusa
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

10.  Activation of A2A adenosine receptors inhibits expression of alpha 4/beta 1 integrin (very late antigen-4) on stimulated human neutrophils.

Authors:  Gail W Sullivan; David D Lee; William G Ross; Jeffrey A DiVietro; Courtney M Lappas; Michael B Lawrence; Joel Linden
Journal:  J Leukoc Biol       Date:  2003-10-02       Impact factor: 4.962

View more
  11 in total

Review 1.  Tumor Microenvironment-A Short Review of Cellular and Interaction Diversity.

Authors:  Aleksandra Bożyk; Kamila Wojas-Krawczyk; Paweł Krawczyk; Janusz Milanowski
Journal:  Biology (Basel)       Date:  2022-06-18

2.  Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression.

Authors:  Zhou Liu; Zhijie Gao; Bei Li; Juanjuan Li; Yangyang Ou; Xin Yu; Zun Zhang; Siqin Liu; Xiaoyu Fu; Hongzhong Jin; Juan Wu; Si Sun; Shengrong Sun; Qi Wu
Journal:  Oncoimmunology       Date:  2022-06-08       Impact factor: 7.723

Review 3.  Deciphering Innate Immune Cell-Tumor Microenvironment Crosstalk at a Single-Cell Level.

Authors:  Ryohichi Sugimura; Yiming Chao
Journal:  Front Cell Dev Biol       Date:  2022-05-13

Review 4.  Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy.

Authors:  Melania Lo Iacono; Chiara Modica; Gaetana Porcelli; Ornella Roberta Brancato; Giampaolo Muratore; Paola Bianca; Miriam Gaggianesi; Alice Turdo; Veronica Veschi; Matilde Todaro; Simone Di Franco; Giorgio Stassi
Journal:  Biomolecules       Date:  2022-05-14

Review 5.  Tumour Microenvironment-Immune Cell Interactions Influencing Breast Cancer Heterogeneity and Disease Progression.

Authors:  Keely Tan; Matthew J Naylor
Journal:  Front Oncol       Date:  2022-05-13       Impact factor: 5.738

6.  Obesity modulates the immune macroenvironment associated with breast cancer development.

Authors:  Aleida Núñez-Ruiz; Flor Sánchez-Brena; Cynthia López-Pacheco; Naray A Acevedo-Domínguez; Gloria Soldevila
Journal:  PLoS One       Date:  2022-04-26       Impact factor: 3.752

Review 7.  Lipotoxicity as a Barrier for T Cell-Based Therapies.

Authors:  Romy Böttcher-Loschinski; Judit Rial Saborido; Martin Böttcher; Sascha Kahlfuss; Dimitrios Mougiakakos
Journal:  Biomolecules       Date:  2022-08-25

Review 8.  Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias.

Authors:  Xingjian Zhai; Xiaoyan Jiang
Journal:  Biomedicines       Date:  2022-07-30

Review 9.  IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment.

Authors:  Kewei Liu; Ai Huang; Jun Nie; Jun Tan; Shijie Xing; Yue Qu; Ke Jiang
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

Review 10.  Combination strategies with PD-1/PD-L1 blockade: current advances and future directions.

Authors:  Ming Yi; Xiaoli Zheng; Mengke Niu; Shuangli Zhu; Hong Ge; Kongming Wu
Journal:  Mol Cancer       Date:  2022-01-21       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.